Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single‐institution retrospective study

Background Survival outcomes in recurrent head and neck squamous cell carcinoma (HNSCC) are poor. This study aimed to compare survival outcomes between salvage surgery and immunotherapy in patients with recurrent advanced HNSCC. Methods Patients with advanced stage (stage III or IV) recurrent HNSCC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Head & neck 2022-11, Vol.44 (11), p.2465-2472
Hauptverfasser:	Konuthula, Neeraja, Do, Olivia A., Gobillot, Ted, Rodriguez, Cristina P., Futran, Neal D., Houlton, Jeffrey, Barber, Brittany R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Head & neck cancer Head and neck carcinoma Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - surgery Humans Immune Checkpoint Inhibitors Immunotherapy Leukocytes (neutrophilic) Lymphocytes Monoclonal antibodies Mouth Neoplasms - pathology Neoplasm Recurrence, Local - pathology Oral carcinoma Oral cavity Oropharyngeal cancer outcomes Patients pembrolizumab recurrent head and neck cancer Retrospective Studies salvage surgery Salvage Therapy - methods Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck - therapy Surgery Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!